Quick Answer
Cue Biopharma, Inc. reported Shares Outstanding of 96.62 million shares for fiscal year 2025.
Cue Biopharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 96.62M | +56.3% |
| 2024 | 61.82M | +30.9% |
| 2023 | 47.22M | +0.0% |
| 2022 | 47.22M | +46.6% |
| 2021 | 32.20M | +6.1% |
| 2020 | 30.35M | +14.3% |
| 2019 | 26.56M | +28.3% |
| 2018 | 20.70M | +6.4% |
| 2017 | 19.46M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 77.78M | +29.2% | +1.7% |
| June 30, 2025 | 76.45M | +57.2% | +23.7% |
| March 31, 2025 | 61.82M | +27.1% | +0.0% |
| December 31, 2024 | 61.82M | +30.9% | +2.7% |
| September 30, 2024 | 60.21M | +33.4% | +23.8% |
| June 30, 2024 | 48.64M | +11.2% | +0.0% |
| March 31, 2024 | 48.64M | +12.7% | +3.0% |
| December 31, 2023 | 47.22M | +9.7% | +4.6% |
- Cue Biopharma, Inc. showed an increase of +56.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Cue Biopharma, Inc.’s shares outstanding has grown by 396.5% (from 19.46 million shares to 96.62 million shares).
- The most recent figure is from Cue Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: